These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 31003825)
1. Conceptualising access in the direct-acting antiviral era: An integrated framework to inform research and practice in HCV care for people who inject drugs. Høj SB; Jacka B; Minoyan N; Artenie AA; Bruneau J Int J Drug Policy; 2019 Oct; 72():11-23. PubMed ID: 31003825 [TBL] [Abstract][Full Text] [Related]
2. Elimination of hepatitis C virus infection among people who use drugs: Ensuring equitable access to prevention, treatment, and care for all. Grebely J; Hajarizadeh B; Lazarus JV; Bruneau J; Treloar C; Int J Drug Policy; 2019 Oct; 72():1-10. PubMed ID: 31345644 [TBL] [Abstract][Full Text] [Related]
3. "I want to feel young again": experiences and perspectives of young people who inject drugs living with hepatitis C in Vancouver, Canada. Jacob J; Goodyear T; Coulaud PJ; Hoong P; Ti L; Knight R Can J Public Health; 2021 Oct; 112(5):947-956. PubMed ID: 34115340 [TBL] [Abstract][Full Text] [Related]
4. Hepatitis C virus testing, liver disease assessment and treatment uptake among people who inject drugs pre- and post-universal access to direct-acting antiviral treatment in Australia: The LiveRLife study. Bajis S; Grebely J; Hajarizadeh B; Applegate T; Marshall AD; Ellen Harrod M; Byrne J; Bath N; Read P; Edwards M; Gorton C; Hayllar J; Cock V; Peterson S; Thomson C; Weltman M; Jefferies M; Wood W; Haber P; Ezard N; Martinello M; Maher L; Dore GJ; J Viral Hepat; 2020 Mar; 27(3):281-293. PubMed ID: 31698545 [TBL] [Abstract][Full Text] [Related]
5. Reaching hepatitis C virus elimination targets requires health system interventions to enhance the care cascade. Scott N; Doyle JS; Wilson DP; Wade A; Howell J; Pedrana A; Thompson A; Hellard ME Int J Drug Policy; 2017 Sep; 47():107-116. PubMed ID: 28797497 [TBL] [Abstract][Full Text] [Related]
6. "Everybody living with a chronic disease is entitled to be cured": Challenges and opportunities in scaling up access to direct-acting antiviral hepatitis C virus treatment among people who inject drugs. Goodyear T; Ti L; Carrieri P; Small W; Knight R Int J Drug Policy; 2020 Jul; 81():102766. PubMed ID: 32416525 [TBL] [Abstract][Full Text] [Related]
7. Priorities and recommended actions for how researchers, practitioners, policy makers, and the affected community can work together to improve access to hepatitis C care for people who use drugs. Day E; Broder T; Bruneau J; Cruse S; Dickie M; Fish S; Grillon C; Luhmann N; Mason K; McLean E; Trooskin S; Treloar C; Grebely J Int J Drug Policy; 2019 Apr; 66():87-93. PubMed ID: 30743093 [TBL] [Abstract][Full Text] [Related]
8. Integrated models of care for people who inject drugs and live with hepatitis C virus: A systematic review. Socías ME; Karamouzian M; Parent S; Barletta J; Bird K; Ti L Int J Drug Policy; 2019 Oct; 72():146-159. PubMed ID: 31147142 [TBL] [Abstract][Full Text] [Related]
9. Eligibility of persons who inject drugs for treatment of hepatitis C virus infection. Arain A; Robaeys G World J Gastroenterol; 2014 Sep; 20(36):12722-33. PubMed ID: 25278674 [TBL] [Abstract][Full Text] [Related]
10. Prevention, treatment and care of hepatitis C virus infection among people who inject drugs. Bruggmann P; Grebely J Int J Drug Policy; 2015 Feb; 26 Suppl 1():S22-6. PubMed ID: 25245939 [TBL] [Abstract][Full Text] [Related]
11. Ten priorities for expanding access to HCV treatment for people who inject drugs in low- and middle-income countries. Ford N; Wiktor S; Kaplan K; Andrieux-Meyer I; Hill A; Radhakrishnan P; Londeix P; Forette C; Momenghalibaf A; Verster A; Swan T Int J Drug Policy; 2015 Nov; 26(11):1088-93. PubMed ID: 26074094 [TBL] [Abstract][Full Text] [Related]
12. Transitioning from interferon-based to direct antiviral treatment options: A potential shift in barriers and facilitators of treatment initiation among people who use drugs? Makarenko I; Artenie A; Hoj S; Minoyan N; Jacka B; Zang G; Barlett G; Jutras-Aswad D; Martel-Laferriere V; Bruneau J Int J Drug Policy; 2019 Oct; 72():69-76. PubMed ID: 31010749 [TBL] [Abstract][Full Text] [Related]
13. Global policy and access to new hepatitis C therapies for people who inject drugs. Doyle JS; Aspinall EJ; Hutchinson SJ; Quinn B; Gore C; Wiktor SZ; Hellard ME Int J Drug Policy; 2015 Nov; 26(11):1064-71. PubMed ID: 26118794 [TBL] [Abstract][Full Text] [Related]
14. Opportunistic treatment of hepatitis C virus infection (OPPORTUNI-C): study protocol for a pragmatic stepped wedge cluster randomized trial of immediate versus outpatient treatment initiation among hospitalized people who inject drugs. Midgard H; Finbråten AK; Malme KB; Berg-Pedersen RM; Tanum L; Olsen IC; Bjørnestad R; Dalgard O Trials; 2020 Jun; 21(1):524. PubMed ID: 32539853 [TBL] [Abstract][Full Text] [Related]
15. Estimating the cascade of hepatitis C testing, care and treatment among people who inject drugs in Australia. Iversen J; Grebely J; Catlett B; Cunningham P; Dore GJ; Maher L Int J Drug Policy; 2017 Sep; 47():77-85. PubMed ID: 28578863 [TBL] [Abstract][Full Text] [Related]
16. Modelling the elimination of hepatitis C as a public health threat in Iceland: A goal attainable by 2020. Scott N; Ólafsson S; Gottfreðsson M; Tyrfingsson T; Rúnarsdóttir V; Hansdottir I; Hernandez UB; Sigmundsdóttir G; Hellard M J Hepatol; 2018 May; 68(5):932-939. PubMed ID: 29274408 [TBL] [Abstract][Full Text] [Related]
17. Hepatitis C virus control among persons who inject drugs requires overcoming barriers to care. Zeremski M; Zibbell JE; Martinez AD; Kritz S; Smith BD; Talal AH World J Gastroenterol; 2013 Nov; 19(44):7846-51. PubMed ID: 24307778 [TBL] [Abstract][Full Text] [Related]
18. Integrated treatment of hepatitis C virus infection among people who inject drugs: study protocol for a randomised controlled trial (INTRO-HCV). Fadnes LT; Aas CF; Vold JH; Ohldieck C; Leiva RA; Chalabianloo F; Skurtveit S; Lygren OJ; Dalgård O; Vickerman P; Midgard H; Løberg EM; Johansson KA; BMC Infect Dis; 2019 Nov; 19(1):943. PubMed ID: 31703669 [TBL] [Abstract][Full Text] [Related]
19. 'Hep C's like the common cold': understanding barriers along the HCV care continuum among young people who inject drugs. Skeer MR; Ladin K; Wilkins LE; Landy DM; Stopka TJ Drug Alcohol Depend; 2018 Sep; 190():246-254. PubMed ID: 30071457 [TBL] [Abstract][Full Text] [Related]
20. Integrating hepatitis C and addiction care for people who inject drugs in the era of direct-acting antiviral therapy. Bird K; Socías ME; Ti L Int J Drug Policy; 2018 Sep; 59():1-2. PubMed ID: 29960218 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]